Phase I study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors: Updated results of the phase I study

被引：7
|
作者：
Zhou, Qing
Yang, Nong
Zhao, Jun
Zhao, Mingfang
Yu, Yan
Yuan, Ying
Wang, Huijuan
Li, Xingya
Dong, Xiaorong
Sun, Longhua
Zhang, Tongmei
Huang, Dingzhi
Chu, Qian
Huang, Jingjing
Zhang, Sujie
Huang, Mengna
Shen, Yuping
Wu, Yi-Long
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT030
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Phase I study of olaratumab in Japanese patients with advanced solid tumors
    Doi, Toshihiko
    Ma, Yan
    Dontabhaktuni, Aruna
    Nippgen, Cornelia
    Nippgen, Johannes
    Ohtsu, Atsushi
    CANCER SCIENCE, 2014, 105 (07) : 862 - 869
  • [22] A phase I study of resminostat in Japanese patients with advanced solid tumors
    Satoru Kitazono
    Yutaka Fujiwara
    Shinji Nakamichi
    Hidenori Mizugaki
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Eri Inukai
    Osamu Nakamura
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 1155 - 1161
  • [23] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
  • [24] A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
    J. Portnow
    P. Frankel
    S. Koehler
    P. Twardowski
    S. Shibata
    C. Martel
    R. Morgan
    M. Cristea
    W. Chow
    D. Lim
    V. Chung
    K. Reckamp
    L. Leong
    T. W. Synold
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 505 - 514
  • [25] Phase I study of oral rigosertib in patients with advanced solid tumors
    Bowles, Daniel W.
    Diamond, Jennifer Robinson
    Lam, Elaine Tat
    Messersmith, Wells A.
    Weekes, Colin D.
    Leong, Stephen
    Gore, Lia
    Lieu, Christopher Hanyoung
    Freas, Elizabeth
    Ren, Chen
    Wilhelm, Francois
    Eckhardt, S. Gail
    Jimeno, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] A phase I study of oral ixabepilone in patients with advanced solid tumors
    John F. Deeken
    John L. Marshall
    Michael J. Pishvaian
    Jimmy Hwang
    Christoph M. Ahlers
    Pamela L. Clemens
    Susan M. Parker
    Lisa Iacono
    Patricia M. LoRusso
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1071 - 1078
  • [27] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [28] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [29] A phase I study of resminostat in Japanese patients with advanced solid tumors
    Kitazono, Satoru
    Fujiwara, Yutaka
    Nakamichi, Shinji
    Mizugaki, Hidenori
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Inukai, Eri
    Nakamura, Osamu
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (06) : 1155 - 1161
  • [30] Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma
    Fujiwara, Yutaka
    Takahashi, Yasuo
    Okada, Morihito
    Kishimoto, Takumi
    Kondo, Shunsuke
    Fujikawa, Koshi
    Hayama, Manabu
    Sugeno, Masatoshi
    Ueda, Shinya
    Komuro, Keiko
    Lanasa, Mark
    Nakano, Takashi
    ONCOLOGIST, 2022, 27 (09): : E703 - E722
12345